Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Orgenesis stock
Learn how to easily invest in Orgenesis stock.
Orgenesis Inc is a biotechnology business based in the US. Orgenesis shares (ORGS) are listed on the NASDAQ and all prices are listed in US Dollars. Orgenesis employs 151 staff and has a trailing 12-month revenue of around $30 million.
How to buy shares in Orgenesis
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ORGS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Orgenesis stock price (NASDAQ: ORGS)Use our graph to track the performance of ORGS stocks over time.
Orgenesis shares at a glance
|Latest market close||$1.40|
|52-week range||$1.31 - $5.20|
|50-day moving average||$1.77|
|200-day moving average||$2.58|
|Wall St. target price||$9.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.90|
Buy Orgenesis shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Orgenesis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Orgenesis price performance over time
|1 week (2022-09-28)||-4.11%|
|1 month (2022-09-02)||-26.70%|
|3 months (2022-07-05)||-39.13%|
|6 months (2022-04-04)||-58.21%|
|1 year (2021-10-05)||-70.65%|
|2 years (2020-10-05)||-73.18%|
|3 years (2019-10-04)||3.675|
|5 years (2017-10-02)||211.11%|
|Revenue TTM||$30 million|
|Gross profit TTM||$35.5 million|
|Return on assets TTM||-20.33%|
|Return on equity TTM||-59.17%|
|Market capitalisation||$36.3 million|
TTM: trailing 12 months
Orgenesis share dividends
We're not expecting Orgenesis to pay a dividend over the next 12 months.
Have Orgenesis's shares ever split?
Orgenesis's shares were split on a 1:12 basis on 16 November 2017. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Orgenesis shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Orgenesis shares which in turn could have impacted Orgenesis's share price.
Orgenesis share price volatility
Over the last 12 months, Orgenesis's shares have ranged in value from as little as $1.31 up to $5.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Orgenesis's is 0.7223. This would suggest that Orgenesis's shares are less volatile than average (for this exchange).
Orgenesis Inc. , a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011.
Frequently asked questionsWhat percentage of Orgenesis is owned by insiders or institutions?
Currently 8.542% of Orgenesis shares are held by insiders and 14.697% by institutions. How many people work for Orgenesis?
Latest data suggests 151 work at Orgenesis. When does the fiscal year end for Orgenesis?
Orgenesis's fiscal year ends in November. Where is Orgenesis based?
Orgenesis's address is: 20271 Goldenrod Lane, Germantown, MD, United States, 20876 What is Orgenesis's ISIN number?
Orgenesis's international securities identification number is: US68619K2042 What is Orgenesis's CUSIP number?
Orgenesis's Committee on Uniform Securities Identification Procedures number is: 68619K105
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert